Table of Contents Author Guidelines Submit a Manuscript
Journal of Pathogens
Volume 2018, Article ID 1018694, 24 pages
Research Article

QSAR Modeling and Molecular Docking Analysis of Some Active Compounds against Mycobacterium tuberculosis Receptor (Mtb CYP121)

Department of Chemistry, Ahmadu Bello University, Zaria, Nigeria

Correspondence should be addressed to Shola Elijah Adeniji; moc.liamg@3434alohs

Received 28 January 2018; Revised 26 February 2018; Accepted 13 March 2018; Published 10 May 2018

Academic Editor: Nongnuch Vanittanakom

Copyright © 2018 Shola Elijah Adeniji et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. St. Cole, R. Brosch, J. Parkhill et al., “Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence,” Nature, vol. 393, pp. 537–544, 1998. View at Google Scholar
  2. G. Lamichhane, J. S. Freundlich, S. Ekins, N. Wickramaratne, S. T. Nolan, and W. R. Bishai, “Essential metabolites of mycobacterium tuberculosis and their mimics,” mBio, vol. 2, no. 1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. M. M. Madkour, Tuberculosis, Springer, Berlin, Germany, 2004. View at Publisher · View at Google Scholar
  4. D. Sarkar, S. R. Deshpande, S. P. Maybhate et al., “1,2,4-Triazole Derivatives and Their Anti-Microbial Activity,” 2016.
  5. C. Hansch and A. Leo, Substituent Constants for Correlation Analysis in Chemistry and Biology, Wiley, 1979.
  6. K. Y. Wong, A. G. Mercader, L. M. Saavedra, B. Honarparvar, G. P. Romanelli, and P. R. Duchowicz, “QSAR analysis on tacrine-related acetylcholinesterase inhibitors,” Journal of Biomedical Science, vol. 21, no. 1, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Larif, S. Chtita, A. Adad, R. Hmamouchi, M. Bouachrine, and T. Lakhlifi, “Predicting biological activity of Anticancer Molecules 3-ary l-4-hydroxyquinolin-2-(1H)-one by DFT-QSAR models,” International Journal of Clinical and Experimental Medicine, vol. 3, pp. 32–42, 2013. View at Google Scholar
  8. M. A. Lill and M. L. Danielson, “Computer-aided drug design platform using PyMOL,” Journal of Computer-Aided Molecular Design, vol. 25, no. 1, pp. 13–19, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. P. C. D. Hawkins, A. G. Skillman, and A. Nicholls, “Comparison of shape-matching and docking as virtual screening tools,” Journal of Medicinal Chemistry, vol. 50, no. 1, pp. 74–82, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. A. D. Becke, “Becke’s three parameter hybrid method using the LYP correlation functional,” The Journal of Chemical Physics, vol. 98, pp. 5648–5652, 1993. View at Google Scholar
  11. C. Lee, W. Yang, and R. G. Parr, “Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density,” Physical Review B, vol. 37, no. 2, p. 785, 1988. View at Publisher · View at Google Scholar · View at Scopus
  12. P. Singh, “Quantitative structure-activity relationship study of substituted-[1, 2, 4] oxadiazoles as s1p1 agonists,” Journal of Current Chemical and Pharmaceutical Sciences, vol. 3, 2013. View at Google Scholar
  13. N. Minovski, Š. Župerl, V. Drgan, and M. Novič, “Assessment of applicability domain for multivariate counter-propagation artificial neural network predictive models by minimum Euclidean distance space analysis: A case study,” Analytica Chimica Acta, vol. 759, pp. 28–42, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. J. H. Friedman, “Multivariate adaptive regression splines,” The Annals of Statistics, vol. 19, no. 1, pp. 1–67, 1991. View at Publisher · View at Google Scholar · View at MathSciNet
  15. U. Abdulfatai, A. Uzairu, and S. Uba, “Quantitative structure activity relationship study of anticonvulsant activity of a_substituted acetamido-N-benzylacetamide derivatives,” Cogent Chemistry, vol. 2, Article ID 1166538, 2016. View at Google Scholar
  16. A. Tropsha, P. Gramatica, and V. K. Gombar, “The importance of being earnest: validation is the absolute essential for successful application and interpretation of QSPR models,” Molecular Informatics, vol. 22, pp. 69–77, 2003. View at Google Scholar
  17. R. Veerasamy, H. Rajak, A. Jain, S. Sivadasan, C. P. Varghese, and R. K. Agrawal, “Validation of QSAR models-strategies and importance,” International Journal of Drug Design and Discovery, vol. 3, pp. 511–519, 2011. View at Google Scholar
  18. G. M. Eric, A. Uzairu, and P. A. Mamza, “A Quantitative structure-activity relationship (qsar) study of the anti-tuberculosis activity of some quinolones,” Journal of Scientific Research and Reports, vol. 10, pp. 1–15, 2016. View at Google Scholar
  19. A. I. Ogadimma and U. Adamu, “Analysis of selected chalcone derivatives as mycobacterium tuberculosis inhibitors,” Open Access Library Journal, vol. 3, pp. 1–13, 2016. View at Google Scholar
  20. M. Jalali-Heravi and A. Kyani, “Use of computer-assisted methods for the modeling of the retention time of a variety of volatile organic compounds: A PCA-MLR-ANN approach,” Journal of Chemical Information and Computer Sciences, vol. 44, no. 4, pp. 1328–1335, 2004. View at Publisher · View at Google Scholar · View at Scopus